Clinical Research Directory
Browse clinical research sites, groups, and studies.
Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.
Sponsor: Universita degli Studi di Catania
Summary
It is well established in studies across several countries that tobacco smoking is more prevalent among schizophrenic patients than the general population. Electronic cigarettes (e-cigarettes) are becoming increasingly popular with smokers worldwide. To date there are no large randomised trials of e-cigarettes in schizophrenic smokers. A well-designed trial is needed to compare efficacy and safety of these products in this special population.
Official title: Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning: Design of a Randomized Trial. Smoking Cessation And Reduction In Schizophrenia (The SCARIS Study)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
0
Start Date
2022-12
Completion Date
2024-12
Last Updated
2026-05-14
Healthy Volunteers
No
Interventions
Ecig 24 mg nicotine
Cigalike
Ecig 0 mg nicotine
Cigalike
Nicotine free inhalator
Plastic CIG a Like